DOUGLAS LEVINE was named director of the Division of Gynecologic Oncology at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, effective May 15. Levine joins NYU Langone from Memorial Sloan Kettering Cancer Center, where he served as an attending physician and head of the Gynecology Research Laboratory. He also served as...
Readers of The Cancer Letter and listeners of The Cancer Letter Podcast are familiar with the impact of President Donald Trump’s first nine months in office on the field of oncology. Now, the threats posed to oncology are being brought to the attention of a general audience—Jonathan Mahler, staff writer for The New York Times Magazine, wrote an in-depth article about how the Trump administration’s actions have brought chaos, uncertainty, and damage to the oncology research community.
